Article

Bausch & Lomb moves production of contact lens to Ireland

Rochester, NY-Bausch & Lomb will move production and marketing of its PureVision extended-wear contact lens to Ireland while it appeals a series of court decisions declaring that the lenses infringe a U.S. patent held by CIBA Vision.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
Related Content
Ashvattha reports positive phase 2 data for migaldendranib in retinal diseases
May 19th 2025

Ashvattha reports positive phase 2 data for migaldendranib in retinal diseases

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Sylentis releases topline results from phase 2a of SYL1801
May 19th 2025

Sylentis releases topline results from phase 2a of SYL1801

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

(Photo courtesy of Malvina Eydelman, MD)
May 18th 2025

Q&A: Malvina Eydelman, MD, on leading CCOI and catalyzing global ophthalmic innovation

Q&A: Eva Kim, MD, on the value of EVO ICL for patients considering surgery
May 18th 2025

Q&A: Eva Kim, MD, on the value of EVO ICL for patients considering surgery

© 2025 MJH Life Sciences

All rights reserved.